Free shipping on all orders over $ 500

Siremadlin

Cat. No. M7535

All AbMole products are for research use only, cannot be used for human consumption.

Siremadlin Structure
Synonym:

NVP-HDM201; HDM201

Size Price Availability Quantity
1mg USD 65 In stock
5mg USD 145 In stock
10mg USD 240 In stock
25mg USD 440 In stock
50mg USD 680 In stock
100mg USD 1050 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Siremadlin (HDM201) is a novel, highly potent and selective inhibitor of the p53-Mdm2 interaction with affinity constant for Mdm2 in the picomolar range and a selectivity ratio greater than 10000-fold vs Mdm4.

In vitro: Siremadlin (HDM201) binds to the p53 binding-site of the Mdm2 protein, disrupting the interaction of the two proteins and leading to the activation of the p53 pathway. It induces robust p53-dependent cell cycle arrest and apoptosis in human p53 wild-type tumor cells. HDM201 exhibits highly selectivity across a panel of cancer cell lines.

In vivo: Siremadlin (HDM201) displays desirable pharmacokinetic and pharmacodynamic profiles in animals together with excellent oral bioavailability. Application of the compound using various dosing schedules triggers rapid and sustained activation of p53-dependent pharmacodynamic biomarkers resulting in tumor regression in multiple xenografted models of p53 wild-type human cancers.

Protocol (for reference only)
Cell Experiment
Cell lines Melanoma cells
Preparation method Melanoma cells were seeded in 96-well plates 24 h before 72 h of treatment with nutlin-3 RG7388, HDM201, GSK2830371 or combinations. The cells were fixed using Carnoy’s fixative followed by Sulforhodamine B (SRB) assay.
Concentrations 0.2 μM
Incubation time 72 h
Animal Experiment
Animal models Mice
Formulation 0.5% methylcellulose and 0.1% Tween 80
Dosages 100 mg/kg
Administration orally
Chemical Information
Molecular Weight 555.41
Formula C26H24Cl2N6O4
CAS Number 1448867-41-1
Solubility (25°C) 100 mg/mL in DMSO
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Wu CE, et al. Br J Cancer. Targeting negative regulation of p53 by MDM2 and WIP1 as a therapeutic strategy in cutaneous melanoma.

[2] Chapeau EA, et al. Proc Natl Acad Sci U S A. Resistance mechanisms to TP53-MDM2 inhibition identified by in vivo piggyBac transposon mutagenesis screen in an Arf-/- mouse model.

Related Mdm2 Products
Nutlin-3

Nutlin-3 is a selective MDM2 (mouse double minute 2) antagonist with IC50 of 90 nM. Nutlin-3 induces apoptosis in cancer cells. Nutlin-3 treatment induces the expression of MDM2 and p21, and displays potent antiproliferative activity with IC50 of ~1.5 μM in cells with wild-type p53 such as HCT116, RKO and SJSA-1.

NSC 66811

NSC 66811 is a potent MDM2 inhibitor with Ki value of 120 nM, which disrupts MDM2-p53 interaction and activates p53 function.

Nutlin-3a

Nutlin-3a, the active enantiomer of Nutlin-3, is a potent murine double minute (MDM2) inhibitor (IC50=90 nM). Nutlin-3a inhibits the p53/MDM2 interaction with IC50 of 90 nM.

Nutlin-3b

Nutlin-3b is a p53/MDM2 antagonist or inhibitor with IC50 value of 13.6 μM, 150-fold less potent (+)-enantiomer of Nutlin-3 as in comparison with opposite enantiomer Nutlin-3a.

SL-01

SL-01 is a p53-Mdm2 interaction inhibitor with IC50 of 3.18 μM.

  Catalog
Abmole Inhibitor Catalog




Keywords: Siremadlin, NVP-HDM201; HDM201 supplier, Mdm2, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.